Skip to content
2000
Volume 28, Issue 42
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Diabetic nephropathy (DN) is one of the most common complications of diabetes and the main cause of end-stage renal disease (ESRD). The inflammatory response plays a key role in the pathological process of DN. As the most deeply studied inflammasome, NLRP3 should not be overlooked in DN. Its abnormal activation accelerates DN progression. In this review, we summarize our understanding of the structural composition and activation factors of the NLRP3 inflammasome. Moreover, the relationship between NLRP3 inflammasome activation, and the potential of the NLRP3 inflammasome as a therapeutic target for DN will also be discussed.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867328666210705153109
2021-12-01
2025-07-09
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867328666210705153109
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test